Online Finance for Growth course

> Founders of biotech companies
> Tech Transfer Officers
> Investment Analysts
> Policy makers
> Consultants 

> Financial statement analysis
> Making a convincing business case
> Financial feasibility: calculations & valuation
> Negotiating & VC deal terms
> The time value of money and capital budgeting
> Scaling up: financial requirements and best practices
> Securing an exit: the role of investment bankers

> Synchronous online seminars with experts from the field
> Review slidecast at your own pace, learn anywhere at any time, around your existing commitments 
> Work on assignments with fellow participants 
> Frequent interaction with faculty, guest speakers and peers 
> Immersive and interactive learning experience from the safety of your own home

When	Module	Content
26 Oct - 3 Nov 2020	1. The basics of strategic finance: financial statement analysis	What to learn form financial statements? The basics of reading and interpreting balance sheets, profit and loss statements and cash flow statement.
29 Oct - 6 Nov 2020	2. Starting from scatch: what makes a convincing business case	How do non-dilutive funding organizations and venture capitalists evaluate companies before they invest? Experiences from a seasoned investor and an experienced business coach.
6 - 17 Nov 2020	3. Financial feasibility: smart calculations and valuation of biotech companies	Conducting smart calculations with a common spreadsheet tool: advanced use of Excel functions
12 - 20 Nov 2020	4. Negotiating and implementing a deal: venture capital deal terms and optimizing your fiscal position	The most often used venture capital deal terms and the most overlooked clauses. And the practical, fiscal and accountancy aspects of incorporation and financing in the Life Sciences.
20 Nov - 1 Dec 2020	5. Understanding investments: the time value of money and capital budgeting	Why the profits in pharma need to be high, and how to calculate this.
26 Nov - 4 Dec 2020	6. Scaling up: financial requirements and best practices	The role of budget impact and incremental cost-effectiveness
4 - 15 Dec 2020	7. Negotiating a deal: how much is my company worth?	Applying different techniques to valuate companies and to evaluate whether investing in a project is financially interesting
10 - 18 Dec 2020	8. Securing an exit: the role of investment bankers	How to conduct financial calculations for the Life Sciences: industry specific costs, revenues, margins and risk profiling, and perspectives of seasoned investors and investment bankers on valuation of deals

Eric Claassen, Professor Business Management & Entrepreneurship in Health & Life Sciences at Vrije Universiteit Amsterdam

> Bart Bergstein, Board member of various life sciences companies
> Arjan Bisseling, Owner of AsjesBisseling Belastingadviseurs
> Eric Claassen, Professor in Business Management & Entrepreneurship in Health & Life Sciences
> Matteo Milone, Assistant Professor Finance
> Yves Prevoo, Founder & CEO of Easee
> Arjen Siegmann, Associate Professor in Finance
> Harm de Vries, General Partner at Innovation Industries
> Judith Smit, Managing Partner at FFUND
> Karin Bergstein, CFO at Aidence and non-executive board member within life sciences sector
> Frederik Gorter de Vries, Director Corporate Finance Life Sciences & Healthcare at Kempen & Co

 

Admission
> Apply soon as places are limited!
> Standard fee for the course: €1,450
> Deadline of registration is 16 October 2020
All prices are excl. VAT.

ECTS credited
The course has a study load of 6 ECTS (168 hours). You will receive a certificate of attendance after finalizing the course.

Click here to register for this course.

Click here to download the brochure.

If you have questions about the program, please contact Dr. Linda van de Burgwal of the VU University at l.h.m.vande.burgwal@vu.nl. If you have questions about the registration and invoice, please contact us at info@bdplifesciences.com.